The directors of Burr and Burr PLC are pleased to announce the completion of a series of brand acquisitions for the omega-3 health supplement sector.
In two separate transactions, Burr and Burr have acquired the brands OmegaVita (omegavita.no) and GO3 (go3.com).
In addition and as part of the GO3 deal, Burr and Burr have enlisted the industry expertise of Geir Frantzen in order to draw a line in the sand with respect to the sector's consolidation that Burr and Burr have begun.
Mr Franzten, formerly a senior vice president and owner of Findus Group, has years of vital experience in the production and distribution of omega-3 in multiple global markets. He brings vital strategy and growth planning to the brands owned by Burr and Burr. "I am very excited at this development and the chance to build the largest company in the field," said Mr Frantzen.
Chris Thornblom, interim CEO said, "We are well underway in our development phase and will continuously seek to acquire additional brands that have a strategic fit with our plan of becoming a leading player in the health supplement field. Additionally, assembling a team of exceptional individuals with strong leadership capabilities, a cohesive work ethic, and the industry expertise to move Burr and Burr's products through various distribution channels."
Burr and Burr boasts its all-natural product will outperform sales of drug versions sold by pharmaceutical companies, given the growing concerns about side effects around synthetic versions. To this end, the branding concept "THIS IS NOT A DRUG" was developed and is being trademarked by Burr and Burr.
"Financing the business was not the easiest and negotiations have been ongoing for over 12 months, but now its concluded I am happy to say it was worth it. We have brought together a number of private equity groups for phase one and now going into the next phase with extreme confidence" said Edward Fitzpatrick of Cazord Capital Limited.